The Effect of Stromal Vascular Fraction for Patients with Androgenetic Alopecia

The study "The Effect of Stromal Vascular Fraction for Patients with Androgenetic Alopecia" by Perihan Öztürk and Mehmet Bekerecioğlu involved 20 patients (14 males and 6 females, aged 21-41) with Androgenetic Alopecia. The study aimed to assess the effectiveness of Stromal Vascular Fraction (SVF) treatment, a stem cell-rich specimen. After 3 months of treatment, results showed an increase in hair density and thickness, concluding that SVF is an effective and safe treatment for Androgenetic Alopecia. The document also mentions other studies showing promising results using SVF for hair loss treatment, including SVF-enriched platelet-rich plasma therapy and SVF-enhanced adipose transplantation, but does not provide specific participant numbers for these studies.